Recursion vets launch new startup

The latest stories trending on MedCity News.

Editor's Pick

Top Story Recursion Vets Unveil Startup Noetik, Using AI to Unlock Tumor Biology By revealing how tumors interact with immune cells, Noetik aims to identify new targets for new cancer drugs. The startup and its artificial intelligence-driven platform are supported by $14 million in seed financing. Sponsored Content Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women's Health Presented by AVIA Health and MedCity News Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients - all while using fewer staff resources. If you're building a business case for remote monitoring that seamlessly transitions care from hospital to home, don't miss this opportunity to hear how to effectively navigate the remote monitoring landscape. Sign up today and join the event! Last Call To Tell Us What You Think If you haven't already, please take 3-5 minutes and tell us what you really think. Your input is valuable and will help us improve MedCity News. As a thank you for your time, you can enter to win a $250 gift card. Take Survey Now

Featured News

Seagen and Nurix Join Forces to Develop a New Class of Cancer Medicines Seagen and Nurix are bringing their respective technologies together to develop a new class of cancer drugs called degrader antibody conjugates. Nurix CEO Arthur Sands says the multi-year, multi-target collaboration expands the reach of each company's technology. Alignment Health: What Are Seniors' Top Barriers to Care? A new survey from Alignment Health found that economic instability, food insecurity, lack of support and transportation access are the biggest social barriers for seniors. 4 Steps Needed to Improve Patient Safety On a National Level, Per PCAST The President's Council of Advisors on Science and Technology (PCAST) issued a report that laid out four recommendations to improve patient safety across the nation. Some of these included creating federal leadership positions focused on advancing patient safety and hastening research on systems of safe care. Abbott-Bigfoot Deal Proves That Diabetes Is a Hot Area for Digital Health Investment This week, Abbott announced its plans to acquire Bigfoot Biomedical — a startup selling a "smart" insulin pen cap, which collects data from a user's CGM to help them calculate the right dose. Most analysts were unsurprised to hear of the acquisition given that the two companies have been collaborating for more than six years, but they said the deal reinforces the steady pace of digital innovation in the diabetes care space. MA Beneficiaries With Cancer Spend Less on Healthcare Than Traditional Medicare Beneficiaries Medicare Advantage beneficiaries with a cancer diagnosis spend $3,996 on out-of-pocket costs and premiums annually, versus $6,091 for traditional Medicare beneficiaries with cancer, a new report found.

Resources

MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe